These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 20038538

  • 1. Immunization with a combination of three pneumococcal proteins confers additive and broad protection against Streptococcus pneumoniae Infections in Mice.
    Wu K, Zhang X, Shi J, Li N, Li D, Luo M, Cao J, Yin N, Wang H, Xu W, He Y, Yin Y.
    Infect Immun; 2010 Mar; 78(3):1276-83. PubMed ID: 20038538
    [Abstract] [Full Text] [Related]

  • 2. Intranasal Immunization with the Commensal Streptococcus mitis Confers Protective Immunity against Pneumococcal Lung Infection.
    Shekhar S, Khan R, Schenck K, Petersen FC.
    Appl Environ Microbiol; 2019 Mar 15; 85(6):. PubMed ID: 30683742
    [Abstract] [Full Text] [Related]

  • 3. Caseinolytic protease: a protein vaccine which could elicit serotype-independent protection against invasive pneumococcal infection.
    Cao J, Li D, Gong Y, Yin N, Chen T, Wong CK, Xu W, Luo J, Zhang X, Lam CW, Yin Y.
    Clin Exp Immunol; 2009 Apr 15; 156(1):52-60. PubMed ID: 19220325
    [Abstract] [Full Text] [Related]

  • 4. Protection against pneumococcal infection elicited by immunization with multiple pneumococcal heat shock proteins.
    Cao J, Zhang X, Gong Y, Zhang Y, Cui Y, Lai X, Yin Y, Li M, Li D, Zhang L.
    Vaccine; 2013 Aug 02; 31(35):3564-71. PubMed ID: 23727004
    [Abstract] [Full Text] [Related]

  • 5. Serotype-independent protection against pneumococcal infections elicited by intranasal immunization with ethanol-killed pneumococcal strain, SPY1.
    Xu X, Meng J, Wang Y, Zheng J, Wu K, Zhang X, Yin Y, Zhang Q.
    J Microbiol; 2014 Apr 02; 52(4):315-23. PubMed ID: 24682994
    [Abstract] [Full Text] [Related]

  • 6. Multivalent Pneumococcal Protein Vaccines Comprising Pneumolysoid with Epitopes/Fragments of CbpA and/or PspA Elicit Strong and Broad Protection.
    Chen A, Mann B, Gao G, Heath R, King J, Maissoneuve J, Alderson M, Tate A, Hollingshead SK, Tweten RK, Briles DE, Tuomanen EI, Paton JC.
    Clin Vaccine Immunol; 2015 Oct 02; 22(10):1079-89. PubMed ID: 26245351
    [Abstract] [Full Text] [Related]

  • 7. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
    Cao J, Chen D, Xu W, Chen T, Xu S, Luo J, Zhao Q, Liu B, Wang D, Zhang X, Shan Y, Yin Y.
    Vaccine; 2007 Jun 28; 25(27):4996-5005. PubMed ID: 17524530
    [Abstract] [Full Text] [Related]

  • 8. c-di-GMP is an effective immunomodulator and vaccine adjuvant against pneumococcal infection.
    Ogunniyi AD, Paton JC, Kirby AC, McCullers JA, Cook J, Hyodo M, Hayakawa Y, Karaolis DK.
    Vaccine; 2008 Aug 26; 26(36):4676-85. PubMed ID: 18640167
    [Abstract] [Full Text] [Related]

  • 9. Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide.
    Lu YJ, Forte S, Thompson CM, Anderson PW, Malley R.
    Infect Immun; 2009 May 26; 77(5):2076-83. PubMed ID: 19255193
    [Abstract] [Full Text] [Related]

  • 10. Mucosal and systemic immunization with a novel attenuated pneumococcal vaccine candidate confer serotype independent protection against Streptococcus pneumoniae in mice.
    Wu K, Yao R, Wang H, Pang D, Liu Y, Xu H, Zhang S, Zhang X, Yin Y.
    Vaccine; 2014 Jul 16; 32(33):4179-88. PubMed ID: 24945468
    [Abstract] [Full Text] [Related]

  • 11. Combination of pneumococcal surface protein A (PspA) with whole cell pertussis vaccine increases protection against pneumococcal challenge in mice.
    Oliveira ML, Miyaji EN, Ferreira DM, Moreno AT, Ferreira PC, Lima FA, Santos FL, Sakauchi MA, Takata CS, Higashi HG, Raw I, Kubrusly FS, Ho PL.
    PLoS One; 2010 May 27; 5(5):e10863. PubMed ID: 20523738
    [Abstract] [Full Text] [Related]

  • 12. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae.
    Denoël P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT.
    Vaccine; 2011 Jul 26; 29(33):5495-501. PubMed ID: 21624422
    [Abstract] [Full Text] [Related]

  • 13. Protection against pneumococcal infection elicited by immunization with glutamyl tRNA synthetase, polyamine transport protein D and sortase A.
    Min X, Zhang X, Wang H, Gong Y, Li M, Xu W, Yin Y, Cao J.
    Vaccine; 2012 May 21; 30(24):3624-33. PubMed ID: 22464966
    [Abstract] [Full Text] [Related]

  • 14. Preclinical evaluation of a chemically detoxified pneumolysin as pneumococcal vaccine antigen.
    Hermand P, Vandercammen A, Mertens E, Di Paolo E, Verlant V, Denoël P, Godfroid F.
    Hum Vaccin Immunother; 2017 Jan 02; 13(1):220-228. PubMed ID: 27768518
    [Abstract] [Full Text] [Related]

  • 15. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C, Lin H, Huang J, Wang H, Cai Q, Fang L, Guo Y.
    Microb Pathog; 2009 Sep 02; 47(3):151-6. PubMed ID: 19467319
    [Abstract] [Full Text] [Related]

  • 16. Mucosal immunization with purified ClpP could elicit protective efficacy against pneumococcal pneumonia and sepsis in mice.
    Cao J, Chen T, Li D, Wong CK, Chen D, Xu W, Zhang X, Lam CW, Yin Y.
    Microbes Infect; 2008 Sep 02; 10(14-15):1536-42. PubMed ID: 18930162
    [Abstract] [Full Text] [Related]

  • 17. A pneumococcal vaccine combination with two proteins containing PspA families 1 and 2 can potentially protect against a wide range of Streptococcus pneumoniae strains.
    Yu J, Chen X, Li B, Gu T, Meng X, Kong W, Wu Y.
    Immunol Res; 2018 Aug 02; 66(4):528-536. PubMed ID: 30128745
    [Abstract] [Full Text] [Related]

  • 18. Resistance of young mice to pneumococcal infection can be improved by oral vaccination with recombinant Lactococcus lactis.
    Villena J, Medina M, Racedo S, Alvarez S.
    J Microbiol Immunol Infect; 2010 Feb 02; 43(1):1-10. PubMed ID: 20434117
    [Abstract] [Full Text] [Related]

  • 19. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
    Xu Q, Pryharski K, Pichichero ME.
    Vaccine; 2017 Jan 05; 35(2):337-344. PubMed ID: 27919628
    [Abstract] [Full Text] [Related]

  • 20. Polyvalent 23 epitope polysaccharide pneumonia vaccine induced effective protection through strain-adapted effector mechanisms as demonstrated by the different cytokine responses in mice challenged with two different strains of Streptococcus pneumoniae.
    Mohler J, Moine P, Azoulay-Dupuis E, Henin D, Fantin B.
    Eur Cytokine Netw; 2007 Mar 05; 18(1):23-30. PubMed ID: 17400535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.